Getting older often brings a higher susceptibility to a wide array of illnesses. So why not aim to regain some of the youth we lose with time?
We stand at the threshold of a luminous era in biosciences, driven by sweeping advances in molecular biology. Breakthroughs in precise gene editing, mRNA vaccines, targeted cancer therapies, and more are reshaping the field of biomedicine.
Move Over, Wegovy and Zepbound
Retatrutide, a novel medicine for diabetes and weight management that engages three distinct receptors in the brain and body, proves even more potent than earlier GLP-1 therapies. In early-stage trials, participants shed an average of about 70 pounds over 80 weeks. Millions of Americans dealing with diabetes and/or obesity have benefited from GLP-1 medications, and adult obesity rates have begun to ease largely due to their introduction. GLP-1 drugs also cut the risk of heart attacks, reverse fatty liver disease, slow the progression of chronic kidney disease, and effectively address sleep apnea. Although retatrutide has not yet undergone FDA review or approval, illegal versions are popular among biohackers.
Get Your Lipoprotein(a) Level Tested
Lipoprotein(a), or Lp(a), is a particularly perilous form of cholesterol that can triple the likelihood of a heart attack. Your genes largely determine your Lp(a) levels. For decades, cardiologists have known that roughly 20 percent of Americans carry elevated Lp(a), yet routine testing has not been routinely offered. Why? Because there were no treatments to lower it. Even if patients want to know their risk for personal reasons, such as planning a career, the information has often been unavailable. In April, the medical establishment finally advised patients to undergo a one-time blood test to determine their Lp(a) levels. Fortunately, therapies aimed at lowering Lp(a) may be on the horizon. Early trials indicate that small interfering RNA drugs can shut down Lp(a) production in the liver, reducing levels by 80 percent to 94 percent.
New Infectious Disease Vaccines
With the FDA’s blessing, a powerful new mRNA influenza vaccine offering broad protection across multiple virus strains could be available in the coming flu season. Lyme disease infects more than 620,000 Americans each year. Yet, because of legal action by trial lawyers, a vaccine against this tick-borne illness has not been accessible. That situation may change: this year, Pfizer and Valneva reported their vaccine is about 70 percent effective at preventing Lyme disease. Globally, about 91 million people have been infected with HIV, and 44 million have died from the disease. Researchers at the La Jolla Institute for Immunology and the Scripps Research Institute report progress on a vaccine that elicits broadly neutralizing antibodies against HIV in primates. A preliminary human trial began earlier this year.
Sequence Your Whole Genome on the Cheap
Back in 2009, I paid 1,000 dollars to 23andMe for a genotyping test covering roughly 555,000 single nucleotide polymorphisms (SNPs). That test captured around 5 percent of common human SNPs, yielding health predisposition reports, carrier status, and ancestry insights. Recently, I paid sequencing.com 399 dollars to sequence my entire genome. The company analyzes my genetic data against more than 15,000 diseases, rare conditions, traits, and medication responses.
Cancer Vaccine Progress
Vaccines that target cancer-causing pathogens—such as HPV and Hepatitis B—have been highly effective for many years. Now researchers are developing therapeutic mRNA vaccines designed to train patients’ immune systems to attack their cancers. A preliminary 2026 study reported that seven of eight patients who responded to a pancreatic cancer vaccine were still alive four to six years after surgery. Even more encouraging, researchers are beginning to develop vaccines that prompt a preventative immune response to common cancer-driving mutations before tumors arise. In an early preventative trial, none of the participants with a genetic predisposition or concerning cysts developed pancreatic cancer.
Human Reproduction Breakthroughs
In May, Paterna Biosciences announced that it had grown fully functional human sperm entirely outside the body. The lab-grown sperm were used to successfully fertilize human eggs. In June, the biotechnology firm Conception revealed that its researchers had transformed blood cells into mini ovaries containing millions of potential egg cells. That same month, a team at Columbia University demonstrated how a precise version of CRISPR genome editing could correct a specific mutation in early-stage human embryos. (Not surprisingly, the achievement drew bioethical warnings that wealthy individuals might merge this technology with in vitro fertilization to optimize their offspring.)
Reversing the Clock
Aging makes you more susceptible to all kinds of illnesses. So why not aim to regain youth? Much research centers on the Yamanaka factors, a quartet of proteins discovered by Nobel laureate Shinya Yamanaka that can reprogram old cells into youthful stem cells. Life Biosciences is launching a clinical trial using three of the Yamanaka factors to restore sight by resetting aged, damaged cells to a more youthful gene-expression profile. Several other startups, including Altos Labs, Retro Biosciences, and Rejuvenate Bio, are pursuing this approach to extend healthspan and longevity through cellular rejuvenation. More adventurous (and possibly reckless) anti-aging enthusiasts might consider a visit to Minicircle’s clinic in Próspera, the Honduran charter city, for Klotho injections. The company’s gene therapy boosts production of the Klotho protein, which has been shown to improve physical and cognitive health and extend lifespan in mice.
As compelling as this brief survey of biomedical advances is, I urge everyone involved to hurry. None of us is getting any younger.
